Immune response to enzyme replacement therapy in Fabry disease: impact on clinical outcome?
- PMID: 19062323
- DOI: 10.1016/j.ymgme.2008.10.013
Immune response to enzyme replacement therapy in Fabry disease: impact on clinical outcome?
Comment on
-
A retrospective analysis of the potential impact of IgG antibodies to agalsidase beta on efficacy during enzyme replacement therapy for Fabry disease.Mol Genet Metab. 2009 Jan;96(1):4-12. doi: 10.1016/j.ymgme.2008.10.004. Epub 2008 Nov 20. Mol Genet Metab. 2009. PMID: 19022694 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
